TCTMD

OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke

NEW ORLEANS, LA—Intravenous tenecteplase (TNKase; Genentech) improves functional outcomes versus standard care when ...
The Cardiology Advisor

ASA: IV Tenecteplase Beneficial at 4.5 to 24 Hours After Non-Large Vessel Occlusion Ischemic Stroke

Intravenous tenecteplase administered up to 24 hours after stroke onset is associated with higher likelihood of excellent functional outcome.
MedPage Today on MSN

Thrombolysis window may extend to 24 hours for non-LVO strokes

Caveat in Chinese trial was the increased symptomatic intracranial hemorrhage risk ...